5 Indian-Americans On CNBC Changemakers List

Revathi Advaithi, Sandhya Ganapathy, Dr Geetha Murali, Ritu Narayan, and Aradhana Sarin are among the 50 women on the list.

The CNBC Changemakers: Women Transforming Business list includes five Indian-American women. Revathi Advaithi, Sandhya Ganapathy, Dr Geetha Murali, Ritu Narayan, and Aradhana Sarin.

“The women named to the inaugural CNBC Changemakers list are creating a pattern of what it takes to defy the odds, innovate, and thrive in a volatile business landscape,” a CNBC statement said.

“From startup founders to S&P 500 C-suite growth drivers, from personalities shaking up the media industry to figures taking women’s sports further into the mainstream, the 2024 Changemakers have broken new ground and set the stage for others to follow,” it added.

Advaithi is the chief executive officer of Flex,  a multinational, diversified manufacturing company. Named CEO in 2019, she has helped build the company into one of the most trusted manufacturing partners across a variety of industries. She was also named by US President Joe Biden to the advisory committee for trade policy and negotiations.

Ganapathy took over the helm at EDP Renewables North America as CEO in 2022. The Houston-based company is one of the top five renewable energy operators in the US, operating 60 wind farms and 12 utility-scale solar parks. She has previously worked as an investment banker at HSBC and Morgan Stanley.

As CEO of Room to Read, Murali is dedicated to the eradication of illiteracy and gender inequality through the development of a love of reading in marginalized children. In 2023, the organization launched “She Creates Change,” a multimedia storytelling project intended to broaden its reach by encouraging young women and girls to create change in their communities and achieve educational goals.

Narayan’s Zūm is a transportation company that focuses on students while using technology to create more efficient and environmentally friendly routes. The company raised US$ 140 million in Series E financing in early 2024, putting its valuation at $1.3 billion. The company, which serves thousands of schools, provides guardians with an app, that gives live route notifications to and from school.

Sarin is the executive director and global chief financial officer of pharmaceutical giant AstraZeneca. In November 2023, the company launched its health-tech division Evinova which uses digital technology to develop clinical trials and medicine delivery. Sarin took on the CFO role in 2022, joining from biopharma Alexion, and worked on Wall Street in investment banking for two decades before moving into the pharmaceutical industry.